Company Valuation: Exosens

Data adjusted to current consolidation scope
Fiscal Period: December 2024 2025 2026 2027 2028
Market Cap 1 986.7 2,459 2,897 - -
Change - 149.26% 17.78% - -
Enterprise Value (EV) 1 1,131 2,657 3,056 2,988 2,905
Change - 134.98% 15.03% -2.25% -2.76%
P/E 31.9x 57.7x 33.8x 24.5x 21x
PBR 2.39x 5.51x 5.66x 4.77x 4.06x
PEG 0x 1.5x 0x 0.6x 1.3x
Capitalization / Revenue 2.5x 5.25x 5.12x 4.51x 4.02x
EV / Revenue 2.87x 5.68x 5.41x 4.65x 4.03x
EV / EBITDA 9.54x 17.5x 16.4x 13.9x 11.8x
EV / EBIT 11.9x 20.8x 19.1x 16.2x 13.7x
EV / FCF 20.4x 46.4x 49.5x 35.1x 26.3x
FCF Yield 4.9% 2.16% 2.02% 2.85% 3.81%
Dividend per Share 2 0.1 0.3 0.3582 0.5237 0.6346
Rate of return 0.51% 0.62% 0.63% 0.92% 1.12%
EPS 2 0.61 0.84 1.684 2.325 2.704
Distribution rate 16.4% 35.7% 21.3% 22.5% 23.5%
Net sales 1 394.1 468.2 565.4 642.2 721
EBITDA 1 118.5 151.6 185.9 214.6 245.5
EBIT 1 95.3 127.6 159.7 184.1 211.7
Net income 1 30.7 42.7 78.47 114.5 134.6
Net Debt 1 144.1 197.7 159.6 91 8.443
Reference price 2 19.43 48.45 56.90 56.90 56.90
Nbr of stocks (in thousands) 50,783 50,762 50,911 - -
Announcement Date 03/03/25 23/02/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
34.47x6.31x26.15x0.6% 312B
31.37x3.04x17.55x1.42% 270B
26.08x1.72x12.79x1.75% 170B
20.8x1.97x14.29x2.2% 147B
28.93x4.19x17.53x1.18% 137B
-125.25x1.64x43.48x-.--% 136B
27.66x3.01x13.65x1.49% 128B
21.44x1.82x14.96x1.7% 101B
35.36x8.05x24.87x0.27% 79.22B
Average 11.21x 3.53x 20.59x 1.18% 164.26B
Weighted average by Cap. 14.95x 3.63x 20.76x 1.17%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Exosens

Historical PBR trend

Valuation ratios - PBR - Exosens

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Exosens

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Exosens


Year-on-year evolution of the Yield

Valuation ratios - Yield - Exosens